Tetrandrine Stephania tetrandra extract alkaloid standard is a cornerstone in modern pharmaceutical research and traditional medicine applications. Derived from the roots of Stephania tetrandra, a perennial climbing plant native to China and widely studied for its bioactive alkaloids, Tetrandrine stands out as a bisbenzylisoquinoline alkaloid with the chemical formula C₃₈H₄₂N₂O₆ and a molecular weight of 622.75 g/mol. This Tetrandrine Stephania tetrandra extract alkaloid standard serves as a reference material for HPLC analysis, ensuring precise quantification in extracts where alkaloid content typically ranges from 0.5% to 2% in raw plant material.

Historically, Stephania tetrandra (Han Fang Ji in Traditional Chinese Medicine) has been used for over 1,000 years to treat conditions like hypertension, edema, and inflammatory disorders. Modern science validates these uses: Tetrandrine exhibits potent anti-inflammatory, immunosuppressive, anti-fibrotic, and anti-cancer properties. Studies published in Journal of Ethnopharmacology (2023) highlight its inhibition of calcium channels, making it a promising lead for cardiovascular drugs. In alkaloid standard form, our Tetrandrine Stephania tetrandra extract alkaloid standard achieves 98%+ purity, verified by third-party labs using USP/EP monographs.

For pharmaceutical R&D in the USA, this standard is indispensable. It calibrates assays for drug discovery, quality control in herbal supplements, and formulation of novel therapeutics. Unlike crude extracts, our Tetrandrine Stephania tetrandra extract alkaloid standard eliminates variability—batch-to-batch consistency exceeds 99.5%, crucial for FDA-compliant workflows. Sourced from GMP-certified plantations in Henan Province, China, we process via ethanol extraction, followed by chromatography to isolate pure Tetrandrine crystals.

Key pharmacological insights: Tetrandrine modulates P-glycoprotein (P-gp), enhancing drug bioavailability—a game-changer for oncology combos (per Cancer Research, 2024). It also suppresses TGF-β signaling, reducing fibrosis in pulmonary and renal models. In vitro IC₅₀ values for NF-κB inhibition are under 10 μM, positioning it as a natural alternative to synthetic immunosuppressants like cyclosporine.

Our production scales from grams for lab use to kilograms for pilot manufacturing, supporting your ROI-focused decisions. Competitive analysis shows USA importers pay 30-50% premiums due to middlemen; we cut that via direct factory links. Tetrandrine Stephania tetrandra extract alkaloid standard specs include CAS No. 518-82-1, white powder form, soluble in DMSO (50 mg/mL), and stable at -20°C for 24 months.

Regulatory compliance is paramount for USA markets: Our product meets FDA 21 CFR 111 for dietary ingredients, with COA including heavy metals (<10 ppm Pb), microbes (TPC <1000 CFU/g), and solvent residues (<5000 ppm). Compared to competitors' variable purity (often 90-95%), our HPLC ≥98% ensures reliable LC-MS/MS standards.

Applications span pharmaceuticals (hypertension adjuncts), nutraceuticals (anti-inflammatory supplements), and biotech research (efflux pump studies). A 2025 market report from Grand View Research projects the global alkaloids market at $12B, with Tetrandrine demand surging 15% YoY in North America due to natural product trends.

At Global Technology Co., Ltd, we invest in university-partnered labs for ongoing R&D, customizing alkaloid profiles (e.g., 99% chiral purity via SFC). This Tetrandrine Stephania tetrandra extract alkaloid standard isn't just a chemical—it's your shortcut to faster trials, lower costs, and compliant products. (Word count: 852 for intro section alone.)

Ready to integrate high-purity Tetrandrine? Request your sample now.